word
count
author
contribut
jz
mx
sx
mz
conceiv
design
studi
xli
mx
contribut
literatur
search
write
report
kw
yt
yz
js
contribut
data
collect
hr
xli
bw
mx
zy
cz
jy
zz
contribut
data
analysi
data
interpret
hr
xliu
jx
contribut
revis
manuscript
viru
betacoronaviru
share
two
batderiv
sarslik
coronavirus
distanc
sarscov
around
middl
east
respiratori
syndrom
coronaviru
merscov
around
sar
mer
epidem
pose
threat
global
health
due
high
mortal
rate
sarscov
merscov
global
epidemiolog
data
releas
chines
center
diseas
control
prevent
show
confirm
case
identifi
wuhan
mainland
china
except
wuhan
march
mortal
rate
patient
wuhan
close
world
much
higher
mainland
china
except
wuhan
studi
aim
describ
compar
epidemiolog
demograph
clinic
laboratori
radiolog
characterist
well
complic
treatment
outcom
hospit
patient
nonsever
sever
potenti
risk
factor
sever
factor
associ
death
sever
case
analyz
provid
scientif
data
reliev
sever
case
reduc
mortal
studi
ambispect
cohort
studi
consecut
hospit
patient
enrol
sinofrench
new
citi
branch
tongji
hospit
huazhong
univers
scienc
technolog
wuhan
januari
februari
final
date
followup
march
sinofrench
new
citi
branch
tongji
hospit
one
major
nation
design
hospit
provid
medic
care
adult
patient
wuhan
case
enrol
studi
diagnos
base
interim
guidanc
diagnost
treatment
guidelin
issu
chines
nation
health
committe
version
detect
nucleic
acid
shown
text
onlin
repositori
studi
approv
institut
review
board
tongji
hospit
huazhong
univers
scienc
technolog
written
inform
consent
waiv
light
urgent
need
collect
data
epidemiolog
demograph
data
obtain
facetofac
telephon
interview
clinic
symptom
laboratori
radiolog
find
admiss
well
complic
treatment
outcom
hospit
extract
electron
medic
record
serum
cytokin
measur
admiss
patient
data
crosscheck
consist
final
data
entri
enter
computer
databas
presenc
underli
comorbid
identifi
base
intern
classif
diseas
diagnost
code
complic
admiss
assess
definit
shown
text
onlin
repositori
cardiac
injuri
one
complic
defin
serum
hypersensit
cardiac
troponin
level
higher
pgml
without
acut
coronari
symptom
abnorm
electrocardiogram
clinic
outcom
classifi
discharg
hospit
inhospit
death
sever
defin
accord
clinic
practic
guidelin
infecti
diseas
societi
america
american
thorac
societi
diagnosi
treatment
adult
communityacquir
pneumonia
base
whether
requir
ventilatori
support
admiss
sever
case
upon
admiss
divid
two
cohort
sever
ill
critic
ill
case
descript
statist
median
interquartil
rang
iqr
continu
data
total
patient
enrol
case
includ
studi
one
case
meet
inclus
criteria
exclud
due
inclus
criteria
almost
half
patient
identifi
sever
case
nonsever
case
admiss
case
posit
nucleic
acid
test
preadmiss
comparison
find
nonsever
sever
case
patient
posit
viral
nucleic
acid
test
preadmiss
show
essenti
similar
differ
total
patient
see
tabl
onlin
repositori
epidemiolog
demograph
characterist
shown
tabl
patient
got
infect
hospit
patient
healthcar
worker
patient
famili
member
healthcar
worker
nonsever
case
higher
proport
healthcar
worker
famili
member
sever
case
p
date
onset
first
report
case
decemb
median
time
decemb
onset
day
rang
day
day
median
age
studi
popul
year
iqr
rang
year
year
age
year
older
patient
age
year
older
sever
case
almost
twice
nonsever
case
age
vs
p
slightli
half
patient
male
proport
male
sever
case
higher
nonsever
case
vs
patient
sever
smoker
tabl
asthma
identifi
total
popul
patient
regularli
took
angiotensinconvert
enzym
inhibitor
angiotensin
ii
receptor
blocker
signific
differ
found
nonsever
sever
case
sore
throat
cough
chest
pain
dyspnea
chest
tight
dizzi
confus
headach
myalgia
vomit
diarrhea
abdomin
pain
patient
asymptomat
diagnos
ct
screen
durat
fever
preadmiss
significantli
longer
among
sever
case
compar
nonsever
case
sever
case
experienc
longer
durat
onset
outpati
visit
longer
durat
onset
hospit
compar
nonsever
case
respect
patient
treat
corticosteroid
deliv
oral
intraven
preadmiss
patient
receiv
least
one
follow
antivir
medic
umifenovir
oseltamivir
lopinavirritonavir
ribavirin
ct
scan
patient
evalu
preadmiss
show
multilobar
pulmonari
infiltr
patient
tabl
median
time
onset
pneumonia
diagnos
ct
scan
day
admiss
oxygen
satur
less
room
air
present
patient
sever
case
patient
experienc
lymphopenia
cell
per
mm
patient
thrombocytopenia
cell
per
mm
compar
nonsever
case
inflammationrel
marker
level
hscrp
esr
ferritin
significantli
higher
sever
case
level
procalcitonin
globulin
lactat
dehydrogenas
ldh
ntprobtyp
natriuret
peptid
ntprobnp
ddimer
alanin
aminotransferas
aspart
aminotransferas
total
bilirubin
conjug
bilirubin
blood
urea
nitrogen
creatinin
elev
patient
respect
serum
cytokin
level
significantli
higher
sever
patient
nonsever
patient
sever
case
classifi
critic
ill
requir
respiratori
support
compar
sever
ill
case
time
decemb
onset
shorter
time
onset
outpati
visit
longer
critic
ill
case
see
tabl
onlin
high
procalcitonin
high
ntprobnp
high
ldh
high
ddimer
low
albumin
high
creatinin
observ
critic
ill
case
compar
sever
ill
case
p
critic
ill
patient
receiv
system
corticosteroid
preadmiss
proport
significantli
higher
sever
ill
case
p
compar
nonsever
case
system
corticosteroid
use
preadmiss
common
sever
case
larger
cumul
dose
longer
durat
p
p
respect
stratif
patient
corticosteroid
exposur
present
tabl
onlin
repositori
sever
patient
treat
corticosteroid
higher
ldh
level
compar
sever
patient
without
corticosteroid
use
preadmiss
p
nonsever
case
like
receiv
antivir
drug
preadmiss
includ
umifenovir
oseltamivir
p
respect
sever
case
subgroup
patient
receiv
umifenovir
younger
without
umifenovir
use
p
comparison
baselin
demograph
clinic
characterist
patient
without
antivir
drug
use
reveal
mark
differ
laboratori
find
nonsever
sever
case
subgroup
see
tabl
onlin
repositori
final
logist
regress
model
variabl
age
older
ci
hypertens
ci
ldh
ul
ci
ddimer
mgl
ci
significantli
associ
sever
case
figur
followup
period
complic
assess
includ
acut
respiratori
distress
syndrom
ard
cardiac
injuri
liver
dysfunct
acut
kidney
injuri
bacteremia
diffus
intravascular
coagul
hyperglycemia
studi
provid
comprehens
data
epidemiolog
demograph
clinic
laboratori
radiolog
characterist
well
complic
treatment
outcom
hospit
patient
nonsever
sever
wuhan
almost
half
patient
studi
identifi
sever
case
may
differ
result
previou
studi
proport
patient
age
year
older
higher
studi
nanshan
zhong
studi
vs
respect
time
decemb
onset
patient
longer
day
midjanuari
earli
februari
wuhan
experienc
highest
peak
outbreak
famili
cluster
high
preval
older
adult
longer
wait
access
medic
care
observ
sever
case
compar
nonsever
case
half
patient
experienc
least
two
hospit
visit
may
increas
risk
nosocomi
transmiss
event
diagnosi
treatment
may
delay
due
long
wait
access
medic
care
sever
patient
would
like
develop
ard
die
respiratori
failur
although
current
effect
antivir
drug
prompt
identif
earli
respiratori
support
would
reliev
sever
case
reduc
mortal
sever
diseas
patient
initi
posit
nucleic
acid
test
similar
patient
thu
propos
urgent
time
diagnosi
crucial
earli
intervent
delay
base
nucleic
acid
test
proinflammatori
cytokin
level
associ
develop
ard
studi
sever
patient
studi
markedli
lower
report
adult
popul
wuhan
thu
specul
immun
respons
asthmat
patient
may
counter
inflamm
process
induc
infect
studi
requir
character
immun
respons
inflamm
featur
major
sever
patient
show
rapid
progress
multipl
organ
dysfunct
onset
critic
ill
case
sever
ill
case
may
reflect
higher
virul
earlier
onset
risk
factor
sever
identifi
studi
includ
age
high
ldh
level
high
ddimer
level
consist
previou
report
howev
differ
find
previou
studi
hypertens
comorbid
associ
sever
adjust
age
sex
smoke
statu
distinct
featur
pneumonia
high
sever
patient
studi
may
lead
differ
previou
report
gateway
sar
report
protect
factor
sarscovinduc
lung
injuri
associ
express
hypertens
confirm
previou
studi
fact
may
partli
explain
high
preval
sever
patient
hypertens
ldh
recogn
marker
sever
prognosi
variou
diseas
includ
cancer
infect
high
ldh
level
sever
case
suggest
ldh
may
associ
lung
injuri
tissu
damag
warrant
investig
potenti
mechan
studi
evalu
preadmiss
medic
patient
sever
although
proport
nonsever
case
patient
receiv
oseltamivir
higher
patient
without
oseltamivir
use
stratif
analysi
show
signific
differ
case
subgroup
therefor
oseltamivir
use
may
indic
diseas
sever
patient
receiv
umifenovir
younger
without
umifenovir
use
indic
younger
patient
may
easier
access
drug
prefer
umifenovir
older
age
leukocytosi
high
ldh
level
report
risk
factor
associ
inhospit
death
previou
studi
present
studi
also
reveal
hyperglycemia
relat
increas
mortal
patient
preval
hyperglycemia
may
associ
underli
diabet
corticosteroid
therapi
howev
local
express
pancrea
sar
report
damag
islet
result
hyperglycemia
find
suggest
hyperglycemia
may
also
indic
sever
studi
indic
corticosteroid
use
common
sever
case
nonsever
case
highdos
corticosteroid
use
relat
high
risk
death
sever
patient
highdos
steroid
use
may
indic
diseas
sever
rather
predispos
factor
previou
studi
treatment
methylprednisolon
shown
benefici
patient
develop
ard
howev
critic
ill
case
sign
infect
abnorm
laboratori
find
includ
high
leukocyt
high
procalcitonin
high
ddimer
low
albumin
high
creatinin
level
highdos
corticosteroid
use
use
cautiou
critic
ill
patient
avoid
aggrav
complic
recent
studi
bin
cao
et
al
show
lopinavirritonavir
treatment
offer
signific
benefit
standard
care
hospit
adult
patient
cao
studi
also
report
lopinavirritonavir
led
shorter
median
time
clinic
improv
standard
care
hr
ci
modifi
intentiontotreat
analysi
compar
cao
studi
sever
patient
seriou
lopinavirritonavir
treatment
associ
lower
risk
death
sever
patient
studi
howev
studi
observ
studi
thu
benefit
lopinavirritonavir
sever
patient
need
confirm
limit
current
studi
firstli
epidemiolog
data
collect
respect
recal
bia
might
occur
secondli
miss
data
variabl
detail
inform
ct
scan
may
caus
bia
estim
reduc
repres
sampl
thirdli
laboratori
find
measur
upon
admiss
may
indic
sever
causal
relationship
abnorm
laboratori
find
sever
could
determin
fourthli
studi
observ
studi
limit
term
evalu
efficaci
corticosteroid
antivir
drug
final
absenc
compar
data
patient
admit
critic
ill
patient
limit
studi
conclus
outbreak
caus
widespread
concern
threaten
global
